GlassScriptPhysician profile
Benjamin H Nafziger
NPI 1750677027
$8,278.77
in general payments reported to CMS, 2019-2025
25 companies · $1,959 in 2025
The $1,959 reported for 2025 was more than what 83% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $1,312 · 2021: $21.50 · 2022: $2,799 · 2023: $1,637 · 2024: $326 · 2025: $1,959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,510 · Food and Beverage: $1,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,509.67 |
| Food and Beverage | $1,412.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $4,704.37 | 2019-2023 | |
| Treace Medical Concepts, INC. | $1,670.99 | 2022-2025 | |
| Arthrex, INC. | $480.48 | 2023 | |
| Stryker Corporation | $255.37 | 2022-2025 | Citrefix, Actishield, Prostep |
| Paratek Pharmaceuticals, INC. | $172.38 | 2024-2025 | Nuzyra |
| Smith+Nephew, INC. | $150.07 | 2019-2022 | |
| Kerecis Limited | $124.22 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Kowa Pharmaceuticals America, INC. | $111.99 | 2022-2023 | Seglentis |
| Organogenesis INC. | $98.35 | 2020-2024 | Puraply |
| Amgen INC. | $92.19 | 2024-2025 | Krystexxa |
| Aroa Biosurgery Incorporated | $66.92 | 2022-2025 | |
| Melinta Therapeutics, LLC | $53.00 | 2019 | |
| Merck Sharp & Dohme LLC | $42.81 | 2019 | |
| Paragon 28, INC. | $40.18 | 2019-2024 | Gorilla |
| Bioventus LLC | $34.56 | 2023 | Exogen Ultrasound Bone Healing System, Theragenesis Bilayer Wound Matrix |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $31.43 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Polynovo North America LLC | $29.08 | 2024 | Novosorb Btm |
| Orthofix Medical, INC. | $26.65 | 2019-2022 | |
| Trevena, INC. | $22.24 | 2022 | |
| Nexus Medical Technologies LLC | $15.10 | 2024 | |
| Misonix INC | $13.68 | 2019 | |
| Abbott Laboratories | $12.86 | 2023 | Proclaim |
| Arthrosurface Incorporated | $12.75 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.73 | 2019 | |
| Currax Pharmaceuticals LLC | $4.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Nafziger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.